Yueren Zhou

1.7k total citations
29 papers, 988 citations indexed

About

Yueren Zhou is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yueren Zhou has authored 29 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Hepatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yueren Zhou's work include Liver Disease Diagnosis and Treatment (15 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (10 papers). Yueren Zhou is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (10 papers). Yueren Zhou collaborates with scholars based in United States, United Kingdom and Australia. Yueren Zhou's co-authors include Fernando J. Martínez, Susan Murray, Kevin R. Flaherty, Nabihah Tayob, Bethany B. Moore, Imre Noth, Biao Hu, Vibha N. Lama, MeiLan K Han and Eric S. White and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and CHEST Journal.

In The Last Decade

Yueren Zhou

28 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yueren Zhou United States 12 416 297 250 203 201 29 988
Mickaël Schaeffer France 17 219 0.5× 260 0.9× 54 0.2× 80 0.4× 64 0.3× 42 881
T. Kuroiwa Japan 16 268 0.6× 185 0.6× 91 0.4× 146 0.7× 181 0.9× 35 824
Françoise Driss France 11 129 0.3× 440 1.5× 364 1.5× 413 2.0× 18 0.1× 21 979
Joanne Benson United States 7 69 0.2× 456 1.5× 150 0.6× 524 2.6× 75 0.4× 9 1.2k
Daisuke Hoshi Japan 15 142 0.3× 90 0.3× 101 0.4× 43 0.2× 57 0.3× 53 792
Koji Ishii Japan 14 160 0.4× 132 0.4× 43 0.2× 60 0.3× 60 0.3× 58 748
Antônio Augusto Lopes Brazil 22 974 2.3× 597 2.0× 200 0.8× 44 0.2× 49 0.2× 97 1.5k
Dustin Boothe United States 17 244 0.6× 196 0.7× 93 0.4× 12 0.1× 70 0.3× 40 779
Markus Wahrmann Austria 28 120 0.3× 233 0.8× 39 0.2× 59 0.3× 59 0.3× 70 2.1k

Countries citing papers authored by Yueren Zhou

Since Specialization
Citations

This map shows the geographic impact of Yueren Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueren Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueren Zhou more than expected).

Fields of papers citing papers by Yueren Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yueren Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueren Zhou. The network helps show where Yueren Zhou may publish in the future.

Co-authorship network of co-authors of Yueren Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yueren Zhou. A scholar is included among the top collaborators of Yueren Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yueren Zhou. Yueren Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gordon, Stuart C., Yueren Zhou, Talan Zhang, et al.. (2023). Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct‐acting antivirals. Journal of Viral Hepatitis. 30(6). 544–550. 5 indexed citations
2.
González, Humberto C., Mei Lü, Yueren Zhou, et al.. (2023). Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic. Hepatology International. 17(6). 1637–1644. 1 indexed citations
3.
González, Humberto C., et al.. (2022). Alcohol‐related hepatitis admissions increased 50% in the first months of the COVID‐19 pandemic in the USA. Liver International. 42(4). 762–764. 22 indexed citations
4.
Cassidy‐Bushrow, Andrea E., Albert M. Levin, Jia Li, et al.. (2021). Social distancing during the COVID-19 pandemic: quantifying the practice in Michigan – a “hotspot state” early in the pandemic – using a volunteer-based online survey. BMC Public Health. 21(1). 245–245. 9 indexed citations
5.
Lü, Mei, Jia Li, Yueren Zhou, et al.. (2021). Trends in Cirrhosis and Mortality by Age, Sex, Race, and Antiviral Treatment Status Among US Chronic Hepatitis B Patients (2006-2016). Journal of Clinical Gastroenterology. 56(3). 273–279. 5 indexed citations
6.
Zhou, Yueren, Jia Li, Stuart C. Gordon, et al.. (2021). Laboratory monitoring and antiviral treatment for chronic hepatitis B among routine care patients in the United States. Journal of Viral Hepatitis. 29(3). 189–195. 2 indexed citations
7.
Alexander, Gwen, et al.. (2021). Influence of a One-Time Web-Based Provider Intervention on Patient-Reported Outcomes After the Well-Child Visit: A Feasibility Study. SHILAP Revista de lepidopterología. 8(1). 48–57. 1 indexed citations
8.
Li, Jia, Mei Lü, Yueren Zhou, et al.. (2021). Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA. Digestive Diseases and Sciences. 67(8). 4170–4180. 5 indexed citations
9.
Zhou, Yueren, et al.. (2020). Introduction of a community health worker diabetes coach improved glycemic control in an urban primary care clinic. Preventive Medicine Reports. 21. 101267–101267. 4 indexed citations
10.
Trudeau, Sheri, Yueren Zhou, Syed‐Mohammed Jafri, et al.. (2020). African Americans Demonstrate Significantly Lower Serum Alanine Aminotransferase Compared to Non-African Americans. Journal of Racial and Ethnic Health Disparities. 8(6). 1533–1538. 3 indexed citations
11.
Gordon, Stuart C., Yueren Zhou, Jia Li, et al.. (2019). LBP-13-Effect of treatment of hepatitis B patients with tenofovir disoproxil or entecavir on risk of hepatocellular cancer death in a U.S. Cohort. Journal of Hepatology. 70(1). e147–e147. 10 indexed citations
12.
Patel, Sohil H., Laila Poisson, Daniel J. Brat, et al.. (2017). T2–FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project. Clinical Cancer Research. 23(20). 6078–6085. 283 indexed citations
13.
Gordon, Stuart C., Sheri Trudeau, Jia Li, et al.. (2017). Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States. Journal of Clinical Gastroenterology. 53(1). 40–50. 15 indexed citations
14.
Boscarino, Joseph A., Anne C. Moorman, Loralee B. Rupp, et al.. (2017). Comparison of ICD-9 Codes for Depression and Alcohol Misuse to Survey Instruments Suggests These Codes Should Be Used with Caution. Digestive Diseases and Sciences. 62(10). 2704–2712. 21 indexed citations
15.
Zhou, Yueren, Irina V. Haller, Robert J. Romanelli, et al.. (2017). Epidemiologic trends and treatment survival benefits in a US cohort of patients with primary biliary cholangitis (PBC).. 66. 1 indexed citations
16.
Lü, Mei, Yueren Zhou, Irina V. Haller, et al.. (2017). Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment. Clinical Gastroenterology and Hepatology. 16(8). 1342–1350.e1. 92 indexed citations
17.
Salisbury, Margaret L., Meng Xia, Yueren Zhou, et al.. (2015). Idiopathic Pulmonary Fibrosis. CHEST Journal. 149(2). 491–498. 69 indexed citations
18.
Han, MeiLan K., Yueren Zhou, Robert P. Dickson, et al.. (2014). Lung Microbiome Predicts Disease Progression in Idiopathic Pulmonary Fibrosis. Annals of the American Thoracic Society. 11(Supplement_1). S79–S80. 1 indexed citations
19.
Moore, Bethany B., Chris Fry, Yueren Zhou, et al.. (2014). Inflammatory Leukocyte Phenotypes Correlate with Disease Progression in Idiopathic Pulmonary Fibrosis. Frontiers in Medicine. 1(56). 49 indexed citations
20.
Han, MeiLan K, Yueren Zhou, Susan Murray, et al.. (2014). Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. The Lancet Respiratory Medicine. 2(7). 548–556. 285 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mickaël Schaeffer Breakdown of academic impact, for papers by T. Kuroiwa Breakdown of academic impact, for papers by Françoise Driss Breakdown of academic impact, for papers by Joanne Benson Breakdown of academic impact, for papers by Daisuke Hoshi Breakdown of academic impact, for papers by Koji Ishii Breakdown of academic impact, for papers by Antônio Augusto Lopes Breakdown of academic impact, for papers by Dustin Boothe Breakdown of academic impact, for papers by Markus Wahrmann
Rankless by CCL
2026